Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 26, 2016

HeartFlow unveils next generation FFRct Analysis

US-based medical technology company HeartFlow has introduced the next generation of the HeartFlow FFRct Analysis.

US-based medical technology company HeartFlow has introduced the next generation of the HeartFlow FFRct Analysis.

The next generation platform has undergone modifications on process and algorithms which is used by HeartFlow to calculate FFRct values.

HeartFlow chairman and CEO John Stevens said: "This is a major milestone for HeartFlow and a crucial advancement as we see increasing adoption of the HeartFlow Analysis around the world.

"The platform is now characterised with more security measures to cater to the requirement of healthcare institutions across the world."

"With this next generation platform, HeartFlow will be able to deliver results more quickly and securely to the growing number of physicians using the HeartFlow Analysis to aid in the diagnosis of coronary artery disease."

An enhanced new Heartflow platform features advanced algorithms and streamlined case processing which enables a faster generation of HeartFlow Analysis results to clinicians.

Multiple layers of nonlinear algorithms are integrated by deep learning which assists in determining patterns and thereby improving understanding of the information.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

The cloud-based infrastructure of the platform uses Amazon Web Services (AWS) to ensure a secure, robust and scalable delivery of the HeartFlow service.

The platform is now characterised with more security measures to cater to the requirement of healthcare institutions across the world.

HeartFlow co-founder and chief technology officer Charles Taylor said: "One of the benefits of HeartFlow’s cloud-based platform is that the technology utilises the data we receive from our global community of clinicians."

The HeartFlow Analysis is a non-invasive technology which offers an insight into both the extent of coronary artery disease and the impact of disease on blood flow to the heart, enabling clinicians to select an appropriate treatment.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU